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of IMRT, SBRT, and 3D treatments was 50%, 28%, and 
22%,respectively. More than 150 real time adaptive fractions 
were delivered to more than 45 patients. We have also 
demonstrated that the system is capable of determining true 
delivered doses based on daily MR images.  
 
Conclusions: Based on the first two years of clinical 
operation, routine MR-IGRT program is practical, with ability 
of treating a broad spectrum of cancer sites, significant 
number of patients in a day, and systematic delivery of 
advanced and adaptive treatments. 
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The MR-linac combines a 1.5 Tesla MRI and a modern 7MV 
Linac into a single device that can simultaneously produce 
diagnostic quality MRI images and deliver highly conformal 
IMRT based treatments. The introduction of in room MR-linac 
based imaging allows for superior soft tissue contrast of 
tumor and surrounding normal tissues. This functionality 
enables enhanced re-positioning and adaptive radiation 
therapy to account for inter-treatment positioning errors, 
organ deformation, organ movement, and tumor response. 
Additionally, this combined device provides functionality to 
account for intra-treatment motion and has the potential to 
acquire multi-parametric functional sequences at the time of 
treatment. 
The addition of the MR-linac to a radiation therapy clinic 
poses novel challenges related to the the presence of the 
magnetic field and the configuration of the device. Prevailing 
regulations concerning room access, shielding, and adjacency 
to other treatment units and medical equipment must be 
considered when siting the device. Personnel must possess or 
acquire the skill sets and competencies to safely operate an 
MRI and Linac treatment machine. This training should be in 
place prior to installation of the device. Experience with MRI 
based simulation and treatment planning is also a 
prerequisite for MR-linac based treatment delivery. MRI 
based simulation requires attention to the size and material 
of patient positioning devices, MRI coil and table top design. 
Optimal MRI sequences to facilitate region specific tumor and 
normal tissue delineation that may differ from institutional 
diagnostic sequences must be developed. Image distortion is 
routinely managed as part of modern MRI imaging but the use 
of MRI for simulation and the MR-linac for guidance and 
treatment requires a QA process that is nuanced to these 
specific workflows.  
It is anticipated that the work flow for the MRI-linac device 
will be divided into two general scenarios. The first utilizes 
pre-treatment MRI images for patient repositioning to correct 
translational and or rotational errors. This is similar to the 
current cone beam CT image guidance workflow with the 
addition of superior soft tissue contrast. Additionally, the 
intra-fraction imaging will provide superior ability to manage 
tumor motion. The second approach adds plan adaption to 
the MRI based treatment guidance workflow to account for 
deformation, volume, and independent motion changes of 
the targets and organs at risk. The frequency of online or 
offline adaption will depend on the characteristics of tumor 
response and anatomical location.  
An international research consortium has been formed to 
allow for an evidence-based introduction of the MR-linac 
technology and to address how the technology could be used 
to achieve an optimized radiation treatment approach in 
terms of tumor control and toxicity. The MR-linac consortium 
structure is outlined in Figure 1. Nine tumor site groups have 
been selected to start consortium based clinical studies 
based on the expected clinical benefit (either increased local 
control, survival, decreased toxicity or improved quality of 
life). The first nine consortium-broad tumor sites include: 
rectum, esophagus, oropharynx, pancreas, prostate, breast, 
cervix, brain and lung. Each consortium institute coordinates 
one or more Tumor Site Groups (TSG). To achieve the clinical 
introduction of the MR-linac in a safe and step wise manner, 
an adapted version of the IDEAL framework, the R-IDEAL 
(Radiotherapy, Idea, Development, Exploration, Long-term 
study) framework, will be used to conduct the proposed 




Figure 1. Organizational structure clinical working groups MR-
linac Consortium (CSC-clinical steering committee, MAB-
methodology advisory board, DMTF-data management task 
force, TSG-tumor site group) 
References: McCulloch P, Altman DG, Campbell WB, et. al. 
No surgical innovation without evaluation: the IDEAL 
recommendations. Lancet 2009:374:1105-12 
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Soon after the introduction of MRI in radiology it became part 
of treatment planning in radiotherapy and in brachytherapy. 
Especially in gynecological brachytherapy MRI was used 
during the process of target definition. But also in other 
clinical sites MRI before brachytherapy became an essential 
tool for correct staging, treatment decision making and 
target volume definition. The important point was the use of 
MRI with the brachytherapy applicators in-situ. By this 
process the image series contain both, the delivery device 
and the anatomy including tumour, target and organs at risk. 
This enables a real adaptive planning strategy, as the 
treatment planning is based directly on these image series. 
Imaging of a fixed geometry of delivery device inside the 
anatomy is not different to in-room imaging used for external 
beam with a linac or other device as delivery device outside 
the patient. The aim of in room imaging is to depict the 
situation during dose delivery as close as possible. The 
question is how much change of the target and organs at risk 
happens between imaging and dose delivery. In external 
beam this is performed almost simultaneously without 
essential changes, while in brachytherapy the movement of 
patients from an imaging room to a treatment room might 
impose changes. This question was analyzed and debated for 
years, often using inappropriate methodologies as 
registration to bony landmarks. Only recently multicenter 
studies showed that for cervix cancer brachytherapy for 
example the relation of applicators to target is stable with 
minor variations. However, more variation may occur for 
adjacent OARs. Various methods are investigated on how to 
minimize such uncertainties. One is to perform MRI in-room 
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imaging comparable to external beam using dedicated set-
ups with an afterloader inside the MRI room. On the other 
side it seems very promising to invest into in-vivo dosimetry 
methods. Other forms of volumetric imaging in the treatment 
room may be another alternative. As the MR image series for 
treatment planning already contains already the delivery 
device and the anatomy, the situation during dose delivery 
can be verified with different methods with co-registration 
and may reach then almost the same accuracy as if 
performed simultaneously together.  
Real in-room US imaging has been performed since long with 
prostate brachytherapy for direct guidance of needle 
insertion, target definition and on-line dose planning. 
Especially HDR techniques applying ultrasound for treatment 
planning before and during needle insertion, again for 
verification just before dose delivery, leaving the ultrasound 
probe in place and finally performing an ultrasound image 
directly after dose delivery have probably the highest 
accuracy possible. Combining such methods with MRI may 
lead to the ultimate accuracy in terms of target definition, 
OAR localization, treatment planning and dose delivery 
verification.  
Combinations of different imaging techniques with the 
applicator in place, even generated in different rooms, seem 
to be the future in brachytherapy. Already by now 
brachytherapy planning was performed as adaptive 
procedure, taking into account pre-treatment imaging 
information and dose optimization based on the situation 
directly before dose delivery. The adaptive process includes 
image guided applicator placement. The term "in-room 
adaptive imaging" in brachytherapy can be extended to an 
overall definition of a "room" inside the patient visualized via 
adaptive imaging containing target, OARs and the delivery 
device in one image. 
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Good communications are primarily thought to involve skills 
of articulation. However, this presentations makes the case 
for listening as the recurrent starting point in patient 
interactions. Listening is deceptive. Generally viewed as a 
“soft skill” the challenges of listening are easily overlooked. 
Engaging requires gaging (active listening, observing, 
clarifying, and feeding back).  
Drawing upon his experience as an oncology patient and his 
academic background and training in communications and 
social science, Eddie explains why we are prone to assume 
we are good listeners despite evidence to the contrary. 
Demonstrating a number of relevant biases and fallacies, he 
explains why there is no necessary link between assumption 
of competence and actual competence. He presents concrete 
examples from the patient perspective of excellent and poor 
communications and their positive and negative outcomes. 
The presentation concludes with an overview of useful ways 
to reflect upon the issues, improve communications, and 
enhance overall outcomes. 
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Training in communication and interpersonal skills was not 
considered a relevant part of the training at medical school 
and during the specialty residency programmes. Medical 
doctors therefore learned by observation of how their seniors 
performed. After some time one realizes that effective 
communication with patients involve both content and style 
and that being caring, nice and logical is not enough. Based 
on the available literature, this presentation will look into 
the factors influencing the patient-healthcare professional 
communication. I will focus on how healthcare professionals 
are involved in the process of communication and how they 
can improve it.  
When we are visiting a patient we have to ensure that several 
aspects are well covered. First we need to identify the 
patient’s problems and concerns and their impact on their 
family and daily life. Second, we should give clear 
information and advice about their disease, their treatment 
and their prognostic. Giving patients tailored information of 
what and how you think they want to know might be not 
enough. In many occasions breaking bad news is unavoidable, 
and patients may express some strong emotional reactions 
that you should be able to understand and cope with. One 
has also to be aware that some patients do not want to know 
the diagnostic and nothing related to the disease and few 
patients will move into denial. Third, we should ensure that 
patients are aware of the situation, that they have not 
misunderstood the information we have given them and that 
they trust us. It is of paramount importance to empathise 
with the patient. Remember that verbal information goes 
together with visual messages and physical contact. Patient 
depending factors like race, sex, age, language, culture, 
socioeconomic status, disability or communication barriers 
could condition the process of communication. Healthcare 
professional’s factors such as time, job strain, working 
conditions, work engagement and personal life may spoil 
communication with patients.  
Doctors have to be aware that patients today have access to 
information about their disease from their relatives, friends, 
books, media and the Internet that clearly impacts on the 
relation with patients and on the communication process. An 
issue that deserves special attention is the recruitment of 
patients for clinical trials. Patient recruitment partially 
depends on a relation of trust with the patient and in the 
doctor’s ability to communicate the importance of joining a 
trial. It has been shown that training in communication about 
trials may influence in the recruitment. However, trial 
design, especially when one arm offers placebo or less 
treatment, highly contributes to patients’ decline. It has 
been suggested that involving patients and patients’ 
organisations in the design and development of clinical trials 
could accelerate research and make it more effective.  
There is a need for training in communication skills in 
medical education. Training healthcare professionals how to 
be more effective in communication with patients will 
provide a benefit for them as well as for the patients.  
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Patient is the key element of communication. 
Where do we stand regarding communication with our 
patients? Our mission statement: we want to give our 
patients the best possible experience.We really want to 
connect.  
How do we try to achieve this? Personal contact and support 
as much as possible“Do what you say and say what you do”. 
Honest and clear information. Information in common words, 
but also use of visual aids. This is rooted into our Instituut by 
use of a timeline: who explains what at which particular 
stage in the treatment and what tools can be used? Example: 
we inform all our patients in a private briefing before their 
treatment starts.  
The role of the RTT in communication with the patient 
Explanation of the treatmentConnecting with other 
disciplines to support the patiëntA person who a patient can 
approach Provision of personal coaching programme to help 
patients to quit smoking. We check the satisfaction of our 
patients on a regular basis.  
How do we do that? We try to stay in dialogue with our 
patients.All staff are trained for giving and receiving 
feedback.  
What do we try to attempt witch our information 
conversation? The information given before treatment is 
